UK calls for access to new AMD therapies

Article

Quantitative analysis of the impact of neovascular age-related macular degeneration (AMD) on the UK population has led a team of researchers to call for urgent, early access to the new class of drug therapies for the disease.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Related Content
The Eiffel Tower/La Tour Eiffel, as viewed from under a bridge in Paris, France. Concept image for EURETINA 25th anniversary and retina specialist meeting conference in Europe. Image credit: ©Dario – stock.adobe.com

What to expect at this year's European Society of Retina Specialists (EURETINA) Congress

Hattie Hayes
August 26th 2025
Article
PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

August 26th 2025
Podcast
A baby is hugged by their parent in a doctor's office during an exam. Concept image for retinoblastoma diagnosis and treatment, importance of early intervention in paediatric ocular disease. Image credit: ©phoderstock – stock.adobe.com

Patient outcomes in retinoblastoma impacted by parents' interventional delays

Lynda Charters
August 26th 2025
Article
PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

August 26th 2025
Podcast
A glass building with a sign reading "RESERVE BANK." There are $100 Australian bank notes superimposed over the image. Concept image for Mirugen funding, cell reprogramming biologic biotech business of retina care news. Image credit: ©Rose Makin – stock.adobe.com

Australian biotech firm Mirugen secures major funding for cell reprogramming therapy

Hattie Hayes
August 26th 2025
Article
A map of Europe, and a circular frame patterned with the European Union flag, superimposed over binary code, numbers and charts. Concept image for commercialisation licensing business agreement of European pharmaceutical, EMEA ranibizumab biosimilar. Image credit: ©vectorfusionart – stock.adobe.com

Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions

Martin David Harp
August 26th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.